Monopar Therapeutics Inc (MNPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,893 | -13,717 | -8,516 | -5,079 | -2,625 |
| Depreciation Amortization | -800 | -717 | N/A | N/A | -120 |
| Other Working Capital | -474 | 394 | -1,049 | -1,297 | -1,274 |
| Other Operating Activity | 1,693 | 1,838 | 734 | -365 | -1,645 |
| Operating Cash Flow | $-3,474 | $-12,201 | $-8,831 | $-6,741 | $-5,663 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,584 | -63,453 | -1,265 | 862 | -326 |
| Investing Cash Flow | $-5,584 | $-63,453 | $-1,265 | $862 | $-326 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 127,707 | 127,793 | 20 | 15 |
| Common Stock Repurchased | N/A | -35,000 | -35,000 | N/A | N/A |
| Other Financing Activity | -200 | -1,132 | -834 | -453 | -131 |
| Financing Cash Flow | $-200 | $91,574 | $91,959 | $-433 | $-116 |
| Exchange Rate Effect | -32 | 97 | -2 | -3 | 0 |
| Beginning Cash Position | 61,834 | 45,816 | 45,816 | 45,816 | 45,816 |
| End Cash Position | 52,544 | 61,834 | 127,677 | 39,502 | 39,711 |
| Net Cash Flow | $-9,289 | $16,017 | $81,861 | $-6,314 | $-6,105 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,474 | -12,201 | -8,831 | -6,741 | -5,663 |
| Free Cash Flow | -3,474 | -12,201 | -8,831 | -6,741 | -5,663 |